$ Value
$3K
Shares
3,000
Price
$1
Filed
May 16
Insider
Name
Forman Mark S
Title
Chief Medical Officer
CIK
0001922353
Roles
Transaction Details
Transaction Date
2025-05-15
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
3,000
Footnotes
The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Ventyx Biosciences, Inc. 2021 Employee Stock Purchase Plan ("2021 ESPP"), for the ESPP Purchase Period (as defined in the 2021 ESPP) of November 15, 2024 through May 15, 2025. This transaction is also exempt under Rule 16b-3(c). | The relevant Offering Period (as defined in the 2021 ESPP) ended, and the shares were acquired, on the Exercise Date (as defined in the 2021 ESPP) of May 15, 2025. | In accordance with the 2021 ESPP, these shares were purchased based on 85% of the closing price on May 15, 2025.
Filing Info
Forman Mark S's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-04 | VTYX | D | — |
| 2026-03-04 | VTYX | D | — |
| 2026-03-04 | VTYX | D | — |
| 2025-11-17 | VTYX | A | $3K |
| 2025-05-15 | VTYX | A | $3K |
Other Insiders at VTYX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Subramaniam Somu | — | — | 2026-03-04 |
| HULME ALLISON | — | — | 2026-03-04 |
| GUJRATHI SHEILA | — | — | 2026-03-04 |
| White William Richard | — | — | 2026-03-04 |
| Cadoret-Manier Onaiza | — | — | 2026-03-04 |
|
Moore Matthew Richard
Chief Operating Officer
|
— | — | 2026-03-04 |
|
Nuss John
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-03-04 |
|
Mohan Raju
CEO AND PRESIDENT
|
— | — | 2026-03-04 |
|
Forman Mark S
Chief Medical Officer
|
— | — | 2026-03-04 |
|
Gonzales Roy
Senior VP, Finance
|
— | — | 2026-03-04 |